We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Factor Protects Cells From Fatty Acids

By Biotechdaily staff writers
Posted on 31 Jan 2006
Researchers have identified a heart cell protein that responds to the presence of excess saturated fatty acids such as palmitate by initiating a sequence of steps that result in the death of the cell. More...


Investigators at Washington University School of Medicine (St. Louis, MO, USA) had previously worked with a transgenic mouse that accumulated fat in its heart muscle cells resulting in the death of the cells and subsequent heart failure. The cells of these animals contained levels of eEF1A-1 (eukaroytic elongation factor) nearly three-fold higher than those found in the hearts of normal animals.

To discover how eEF1A-1 was involved in fatty acid-induced cell death, the investigators genetically engineered CHO (Chinese hamster ovary) cell mutants resistant to palmitate-induced death, and isolated a clone with inactivated eEF1A-1. They reported in the February 2006 issue of Molecular Biology of the Cell that cells with disrupted eEF1A-1 expression were protected from palmitate lipotoxicity as well as being resistant to hydrogen peroxide- and endoplasmic reticulum (ER) stress-induced death. Lack of eEF1A-1 also resulted in disruption of the cells' actin cytoskeletons when they were exposed to palmitate. This finding suggested that the toxic effect of eEF1A-1 might be related to changes it causes in the cells' cytoskeletal structure.

"Cells have a lot of mechanisms for incorporating fatty acids into storage forms, for metabolizing them or for using them in cellular membranes,” said senior author Dr. Jean Schaffer, associate professor of medicine, molecular biology, and pharmacology at Washington University School of Medicine. "But saturated fats like palmitate are poorly stored in the tiny fat droplets normally found in most cells and therefore are more likely to enter into pathways that lead to cell death such as the one in which eEF1A-1 is involved.”

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Aspiration System
VACUSAFE
New
Thyroid Test
Anti-Thyroid EIA Test
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.